← Leaderboards
Lisa R. Young
Cincinnati Childrens Hosp Med Ctr
$7,622,335
Attributed
$10,425,817
Total exposure
7
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2007–25$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,425,817 · 7
By mechanism
R01$7,491,459 · 3
T32$1,729,714 · 1
K08$639,771 · 1
K24$539,873 · 1
R13$25,000 · 1
Top collaborators
- Sharon Ann Mcgrath-Morrow4 shared
- Xin Sun4 shared
- Benjamin Alexander Raby2 shared
- Darrell N. Kotton1 shared
- David Albert Schwartz1 shared
Most similar at Cincinnati Childrens Hosp Med Ctr
Same institution · by research overlap
- Derek S Wheeler$754,750
- Anil Jegga$689,493
Others in their field
Top investigators on “Lung Diseases”
- Chanza Baytop · Westat, Inc.$271,217,917
- David Heimbrook · Leidos Biomedical Research, Inc.$251,056,084
- Richard K. Wilson · Washington University$201,818,043
- Richard C Boucher · University Of North Carolina Chapel Hill$113,731,309
- James D Crapo · University Of Colorado Denver$90,634,881
- Rebecca Montalvan · Westat, Inc.$86,600,000
Research focus
Lung DiseasesGeneticChildhoodLungPathogenesisAdultMolecularAffectPhenotypeMutationInterstitial Lung DiseasesFunctional DisorderMouse ModelDefectAlveolarMorbidity - Disease RateMacrophageCellsBaseEpithelialInsightExposure ToIn VivoCell Type
Grant awards (31)
INTEGRATIVE GENOMICS OF CHILDHOOD INTERSTITIAL LUNG DISEASE$755,922
R01 · FY2025 · HL
Multidisciplinary Training Program in Pediatric Lung Diseases$445,552
T32 · FY2025 · HL · contact PI
INTEGRATIVE GENOMICS OF CHILDHOOD INTERSTITIAL LUNG DISEASE$844,386
R01 · FY2024 · HL
Multidisciplinary Training Program in Pediatric Lung Diseases$448,176
T32 · FY2024 · HL · contact PI
Multidisciplinary Training Program in Pediatric Lung Diseases$426,555
T32 · FY2023 · HL · contact PI
Deciphering the Mechanisms Underlying Neuroendocrine Cell Hyperplasia of Infancy$545,735
R01 · FY2022 · HL
Multidisciplinary Training Program in Pediatric Lung Diseases$409,431
T32 · FY2022 · HL · contact PI
Midcareer Investigator Award in Patient-Oriented Research in Pediatric Rare Lung Diseases$104,693
K24 · FY2022 · HL · contact PI
Deciphering the Mechanisms Underlying Neuroendocrine Cell Hyperplasia of Infancy$553,853
R01 · FY2021 · HL
Mechanisms of Pulmonary Fibrosis in Hermansky-Pudlak Syndrome$440,000
R01 · FY2021 · HL · contact PI
Midcareer Investigator Award in Patient-Oriented Research in Pediatric Rare Lung Diseases$106,803
K24 · FY2021 · HL · contact PI
Deciphering the Mechanisms Underlying Neuroendocrine Cell Hyperplasia of Infancy$561,096
R01 · FY2020 · HL
Mechanisms of Pulmonary Fibrosis in Hermansky-Pudlak Syndrome$440,000
R01 · FY2020 · HL · contact PI
Midcareer Investigator Award in Patient-Oriented Research in Pediatric Rare Lung Diseases$107,859
K24 · FY2020 · HL · contact PI
Deciphering the Mechanisms Underlying Neuroendocrine Cell Hyperplasia of Infancy$582,925
R01 · FY2019 · HL
Mechanisms of Pulmonary Fibrosis in Hermansky-Pudlak Syndrome$440,000
R01 · FY2019 · HL · contact PI
Midcareer Investigator Award in Patient-Oriented Research in Pediatric Rare Lung Diseases$109,969
K24 · FY2019 · HL · contact PI
Mechanisms of Pulmonary Fibrosis in Hermansky-Pudlak Syndrome$395,000
R01 · FY2018 · HL · contact PI
Midcareer Investigator Award in Patient-Oriented Research in Pediatric Rare Lung Diseases$110,549
K24 · FY2018 · HL · contact PI
Mechanisms of Pulmonary Fibrosis in Hermansky-Pudlak Syndrome$395,000
R01 · FY2017 · HL · contact PI
Mechanisms of Pulmonary Fibrosis in Hermansky-Pudlak Syndrome$395,000
R01 · FY2016 · HL · contact PI
Mechanisms of Pulmonary Fibrosis in Hermansky-Pudlak Syndrome$386,612
R01 · FY2015 · HL · contact PI
Mechanisms of Pulmonary Fibrosis in Hermansky-Pudlak Syndrome$384,650
R01 · FY2014 · HL · contact PI
FASEB SRC on The Lung Epithelium in Health and Disease$25,000
R13 · FY2014 · HL
Mechanisms of Pulmonary Fibrosis in Hermansky-Pudlak Syndrome$371,280
R01 · FY2013 · HL · contact PI
Alveolar Cell Dysfunction and Pulmonary Fibrosis$107,703
K08 · FY2011 · HL · contact PI
Alveolar Cell Dysfunction and Pulmonary Fibrosis$20,547
K08 · FY2011 · HL · contact PI
Alveolar Cell Dysfunction and Pulmonary Fibrosis$128,250
K08 · FY2010 · HL · contact PI
Alveolar Cell Dysfunction and Pulmonary Fibrosis$128,250
K08 · FY2009 · HL · contact PI
Alveolar Cell Dysfunction and Pulmonary Fibrosis$128,250
K08 · FY2008 · HL · contact PI
Alveolar Cell Dysfunction and Pulmonary Fibrosis$126,771
K08 · FY2007 · HL · contact PI